| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5901987 | Journal of Diabetes and its Complications | 2016 | 9 Pages |
Abstract
There is no benefit of a single antihypertensive class in reduction of mortality in hypertensive patients with type 2 diabetes. Reduction of cardiovascular mortality observed in patients treated with ACEi and CCB combination may be related to lower blood pressure levels.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Luciana R. Remonti, Sofia Dias, Cristiane B. Leitão, Caroline K. Kramer, Lucas P. Klassman, Nicky J. Welton, A.E. Ades, Jorge L. Gross,